Immunoassay Additives Reduce Nonspecific Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Immunoassays for detecting PIVKA-II suffer from nonspecific antigen-antibody interactions, leading to reduced sensitivity and accuracy, resulting in potential false positive diagnostic results and delayed or inaccurate diagnoses for hepato-cellular carcinoma.

Innovation Solution

Incorporating additives such as skim milk, saponin, CaCl2, MgCl2, and sulfobetaine zwitterionic detergents into the immunoassay reagents and kits to improve the specificity and sensitivity of PIVKA-II detection by reducing nonspecific binding interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional immunoassay methods are used for detecting PIVKA-II, then the assay can be performed with standard reagents, but nonspecific antigen-antibody interactions occur leading to reduced sensitivity and accuracy

Engineering Contradiction:
Improvesensitivity and accuracy of PIVKA-II detectionVSAvoidnonspecific antigen-antibody interactions
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent introduces additives (skim milk, saponin, CaCl2, MgCl2, and sulfobetaine zwitterionic detergents) as intermediary substances that mediate between the antibody and non-target antigens. These additives selectively inhibit nonspecific binding interactions while preserving specific antibody-antigen binding, thereby resolving the contradiction between maintaining standard assay performance and eliminating harmful nonspecific interactions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the chemical environment parameters of the immunoassay by adding specific substances that change the binding characteristics of antibodies. The additives alter ionic strength, surface tension, and molecular conformation parameters to reduce nonspecific binding affinity while maintaining specific binding, thus improving measurement precision without changing the fundamental assay methodology.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If additives are added to reduce nonsspecific binding, then sensitivity and reliability improve, but the complexity of the reagent composition increases

Engineering Contradiction:
Improvereliability of diagnostic resultsVSAvoidreagent composition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs additives that serve multiple functions simultaneously: skim milk and saponin act as blocking agents and surfactants, while CaCl2 and MgCl2 provide ionic strength adjustment and enzyme cofactor functions. The sulfobetaine detergents provide both nonspecific binding inhibition and foaming prevention. This multi-functionality reduces the need for multiple separate additives, thereby improving reliability without proportionally increasing reagent complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of these additives enhances the sensitivity and reliability of PIVKA-II immunoassays, providing more accurate and timely diagnostic results for hepato-cellular carcinoma, while minimizing the influence of inhibiting substances in the test sample.

Implementation Method 1

nonspecific binding interactions between the antibodies used and antigens other than PIVKA-II that may be present in a sample, reduce sensitivity and accuracy

Methodology Applied
Scientific EffectNonspecific binding inhibition:

Data Source

PatentUS10107826B2Immunoassay methods and reagents for decreasing nonspecific binding
Publication Date: 2018.10.23 ABBOTT JAPAN LLC
  • US10107826B2 patent drawing
  • US10107826B2 patent drawing
  • US10107826B2 patent drawing

AI summary

Methods and kits for reducing non-specific binding in an immunoassay for PIVKA-II in a test sample are described, in which the test sample is reacted with an anti-prothrombin antibody in the presence of one or more of the following additives: skim milk, saponin, CaCl2, MgCl2, and a sulfobetaine zwitterionic detergent.